Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 8/2018

01-08-2018 | Editorial Comment

Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?

Authors: Raphaële Renard-Penna, Mathieu Gauthé, Jean-Noël Talbot

Published in: European Radiology | Issue 8/2018

Login to get access

Abstract

This Editorial Comment refers to the articles “Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population” by Barrett T et al., Eur Radiol. 2017 Dec 8 and “18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients” by Selnæs KM et al., Eur Radiol. 2018 Jan 2.
Literature
1.
Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629CrossRefPubMed
2.
Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815–822
3.
Pokorny MR, de Rooij M, Duncan E et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66:22–29CrossRefPubMed
4.
Barrett T, McLean M, Priest AN et al (2017) Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population. Eur Radiol [Epub]
5.
Nketiah G, Elschot M, Kim E et al (2017) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol 27:3050–3059CrossRefPubMed
6.
Kwee SA, DeGrado TR, Talbot JN et al (2007) Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 37(6):420–428CrossRefPubMed
7.
Balogova S, Zakoun JB, Michaud L et al (2014) Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study. Clin Nucl Med. 39(11):951–959CrossRefPubMed
8.
Mannweiler S, Amersdorfer P, Trajanoski S et al (2009) Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res POR 15:167–172CrossRefPubMed
9.
Schwenck J, Rempp H, Reischl G et al (2017) Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT. Eur J Nucl Med Mol Imaging 44:92–101
10.
Gauthé M, Belissant O, Girard A et al (2017) TEP/TDM et récidive biologique d’adénocarcinome prostatique : apport du 68Ga-PSMA-11 lorsque la 18F-fluorocholine n’est pas contributive. Prog Urol 27:474–481
11.
Selnæs KM, Krüger-Stokke B, Elschot M et al (2018) 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients. Eur Radiol [Epub]
12.
Nanni C, Zanoni L, Pultrone C et al (2016) (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial. Eur J Nucl Med Mol Imaging 43:1601–1610
13.
Calais J, Fendler WP, Herrmann K et al (2017) Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence. J Nucl Med [Epub]
14.
Wieser G, Popp I, Christian Rischke H et al (2017) Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT. Eur J Nucl Med Mol Imaging 44:1463–1472
15.
Zhang J, Niu G, Lang L et al (2017) Clinical translation of a dual integrin αvβ3- and gastrin-releasing peptide receptor-targeting PET radiotracer, 68Ga-BBN-RGD. J Nucl Med 58:228–234CrossRefPubMedPubMedCentral
16.
Maina T, Nock BA, Kulkarni H et al (2017) Theranostic prospects of gastrin-releasing peptide receptor-radioantagonists in oncology. PET Clin 12:297–309CrossRefPubMed
17.
Virgolini I, Decristoforo C, Haug A, et al (2017) Current status of theranostics in prostate cancer. Eur J Nucl Med Mol Imaging
18.
Eiber M, Weirich G, Holzapfel K et al (2016) Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer. Eur Urol 70:829–836CrossRefPubMed
19.
Sidhu HS, Benigno S, Ganeshan B et al (2017) Textural analysis of multiparametric MRI detects transition zone prostate cancer. Eur Radiol 27:2348–2358CrossRefPubMed
20.
Bates A, Miles K (2017) Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer. Eur Radiol 27:5290–5298CrossRefPubMed
Metadata
Title
Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?
Authors
Raphaële Renard-Penna
Mathieu Gauthé
Jean-Noël Talbot
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5459-2

Other articles of this Issue 8/2018

European Radiology 8/2018 Go to the issue

Urogenital

Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population

Neuro

Monitoring cerebral blood flow change through use of arterial spin labelling in acute ischaemic stroke patients after intra-arterial thrombectomy

Musculoskeletal

Imaging complex ventral hernias, their surgical repair, and their complications

Computed Tomography

Presence of multi-segment clot sign on dynamic CT angiography: a predictive imaging marker of recanalisation and good outcome in acute ischaemic stroke patients

Editorial Comment

CT and MRI of pancreatic cancer: there is no rose without a thorn!

Interventional

Sequential high intensity focused ultrasound (HIFU) ablation in the treatment of benign multinodular goitre: an observational retrospective study